Top Markets
#1 Purr Purr +58.83%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +25.62%
#4 ApeX ApeX +21.70%
#5 Fake World Assets Fake World Assets +20.54%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +19.66%
#7 Non-Playable Coin Non-Playable Coin +18.45%
#8 Kinetiq Kinetiq +17.78%
#9 Zora Zora +17.54%
#10 OriginTrail OriginTrail +17.24%
Coin of the day
Purr Purr
Settings
Language
ENGLISH
Currency
USD
Theme
Onconic Therapeutics Onconic Therapeutics

Onconic Therapeutics

476060
Rank in Stocks #21276
Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise,... Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise, primarily dedicated to the discovery and advancement of novel therapeutic solutions. Its research and development initiatives principally focus on creating new medications for acid-related ailments and various oncological conditions. This company was established on May 7, 2020, and maintains its principal office in Seoul, South Korea.
Share Price
$10.04
Last synced: 2026-08-21
Market Cap
$111.12M
Change (1 day)
-1.43%
Change (1 year)
-40.73%
Country
KR
Trade Onconic Therapeutics (476060)

Category

Healthcare
Revenue for Onconic Therapeutics (476060)
Revenue in Aug 2026 TTM: 0
According to Onconic Therapeutics latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Onconic Therapeutics from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH